Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application.

Journal of surgical oncology·2026
Same author

Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib.

Case reports in hematology·2026
Same author

Prolonged KRAS-MAPK Inhibition Induces Interferon Signaling That Promotes Cell State Transition and Confers Therapeutic Vulnerabilities.

Cancer research·2026
Same author

Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

Cancer discovery·2026
Same author

The Phylum Fusobacteriota Is Associated with Colorectal Cancer-Specific Mortality: Results from the Translational Research Program in Cancer Differences across Populations.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Role of lupus nephritis classification systems in everyday clinical practice: a questionnaire-based survey of the Renal Pathology Society (RPS).

Clinical kidney journal·2026

Related Experiment Video

Updated: Jan 12, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.3K

Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity.

Sheela R Damle1,2, Jason A Carter3, Kristin E Goodsell3

  • 1Department of Medicine, University of Washington, Seattle, Washington.

Cancer Immunology Research
|November 7, 2025
PubMed
Summary

Tumor immunity relies on T cell activation. Researchers found that dendritic cell, helper T cell, and cytotoxic T lymphocyte clusters are common in tumors, improving survival by enhancing T cell responses.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.4K
Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

9.8K

Related Experiment Videos

Last Updated: Jan 12, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.3K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.4K
Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

9.8K

Area of Science:

  • Immunology
  • Cancer Biology
  • Spatial Transcriptomics

Background:

  • Effective antitumor immunity depends on cytotoxic CD8+ T cell activation.
  • Intratumoral cell-cell immune interactions are crucial but not fully understood.
  • Spatial colocalization of dendritic cells (DCs), helper T cells (Th), and cytotoxic T lymphocytes (CTL) correlates with response to immunotherapy.

Purpose of the Study:

  • To investigate the prevalence and functional significance of DC:Th:CTL three-cell-type clusters in the tumor immune microenvironment.
  • To determine if these clusters are conserved across different solid tumor types, including immunotherapy-naïve and desmoplastic tumors.
  • To assess the correlation between the density of these immune triads and clinical outcomes.

Main Methods:

  • Integration of over one million spatially resolved single-cell profiles from six spatial proteomic and transcriptomic assays.
  • Analysis of immune cell cluster composition and phenotype in various tumor types, including fibrolamellar carcinoma and pancreatic ductal adenocarcinoma (PDAC).
  • Multiplex immunofluorescence imaging of over 450 primary PDAC tumors to quantify APC:Th:CTL cluster density.

Main Results:

  • DC:Th:CTL three-cell-type clusters are common, even in immunotherapy-naïve and desmoplastic tumors.
  • These immune triads are enriched for specific functional phenotypes: type 1 conventional DCs, mature DCs with immunoregulatory molecules (mregDCs), CXCL13+ Th cells, and GZMK+ effector CTLs.
  • Higher density of APC:Th:CTL clusters in PDAC correlates with increased intratumoral T-cell clonal expansion and improved overall survival.

Conclusions:

  • DC:Th:CTL triads are conserved across diverse solid tumors, indicating a fundamental unit of antitumor immunity.
  • Intratumoral spatial organization of immune cells into specific niches is critical for mediating endogenous antitumor immunity.
  • Targeting or enhancing these spatial immune interactions may represent a promising therapeutic strategy.